Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escalating-dose intravenous clonidine pharmacokinetics in ventilated ICU patients
NL-OMON42780Phase 3Active, not recruiting
- Sponsor
- Deventer Ziekenhuis
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of clonidine in delirium (7 arms), sponsored by Deventer Ziekenhuis. Primary endpoints: Clonidine plasma concentration at predefined early time points, Daily clonidine plasma concentration during treatment and 2 more. Started Feb 2016; status: active, not recruiting.
02
Drugs
clonidine
03
Conditions
delirium
Beyond the preview
Go deeper on NL-OMON42780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42780.